Eddie Pharmaceuticals and PerkinElmer reached a strategic cooperation

In the first year of listing, join hands to develop new cooperation in the field of AIDS diagnosis and treatment

As far as the deployment of both parties in the field of HIV diagnosis and treatment is concerned, 2021 is a crucial "first year of listing"

As a cutting-edge innovative drug R&D company, Aidi Pharmaceuticals is focusing on drug R&D and commercialization in the HIV field

PerkinElmer is a world-renowned technology company with decades of accumulation in infection diagnosis and other fields

Join forces to implement the strategy of "integration of AIDS diagnosis and treatment"

According to the latest data released by the National Health Commission, as of the end of October 2021, 1.

Starting from the strategy of “meeting the urgent needs of domestic AIDS treatment”, Aidi Pharmaceuticals is committed to practicing the concept of “integration of HIV diagnosis and treatment” by building a Chinese->

Taking this strategic cooperation signing as a starting point, the two parties will carry out a series of multi-dimensional business cooperation for the Chinese market in the future, including marketing, clinical research cooperation, and charity activities cooperation

About Addison Pharmaceutical

Jiangsu Aidi Pharmaceutical Co.